Epidemiological and Clinical Changes in RSV-Associated Pneumonia in Children in Mexico Before and During the COVID 19 Pandemic
View abstract on PubMed
Summary
This summary is machine-generated.Respiratory syncytial virus (RSV) infections in children shifted towards summer and autumn, with increased incidence and older affected children during the COVID-19 pandemic. This highlights changes in RSV epidemiology and seasonality.
Area Of Science
- Pediatric infectious diseases
- Epidemiology
- Virology
Background
- Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children.
- Public health measures during the COVID-19 pandemic temporarily reduced RSV transmission.
- An atypical resurgence of RSV was observed in mid-2021.
Purpose Of The Study
- To compare clinical and epidemiological features of RSV infections in Mexican children before and during the COVID-19 pandemic.
- To analyze changes in RSV seasonality, incidence, and affected demographics.
- To identify risk factors for severe RSV-related pneumonia.
Main Methods
- Comparative ambispective longitudinal epidemiological study with two cohorts (2010-2013 and 2021-2023).
- Inclusion of children under five years diagnosed with RSV-related pneumonia.
- Statistical analyses including t-tests, chi-square, and logistic regression; incidence density calculation.
Main Results
- Mean age of affected children increased from 10 to 15 months.
- RSV activity started earlier (summer months) with higher incidence post-2020.
- RSV type B became more prevalent (58.5% vs. 3.8%), and co-infections increased (60% vs. 39%).
Conclusions
- RSV seasonality has shifted towards summer and autumn.
- Increased incidence and infections in older children were observed during the pandemic period.
- Ongoing surveillance is crucial to understand evolving RSV patterns amidst complex public health scenarios.
Related Concept Videos
The pathophysiology of pneumonia involves the following steps:
• Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract.
• Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly...
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
• Pleurisy: indicates the inflammation of the pleura, which causes chest pain and discomfort.
• Pleural Effusion: indicates fluid buildup in the pleural space.
• Atelectasis: Partial collapse of a lung lobe due to mucus blockage or external compression.
• Bacteremia: Bacterial infection entering the bloodstream, commonly seen with...
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
• For...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

